|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
SCIDIR_on1013722829 |
| 003 |
OCoLC |
| 005 |
20231120010225.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
171117t20172017ne a ob 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d YDX
|d N$T
|d EBLCP
|d OPELS
|d OCLCF
|d UPM
|d GZM
|d D6H
|d GZM
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1006380904
|a 1006602460
|a 1018225386
|a 1058955665
|
| 020 |
|
|
|a 0444639497
|q (ebk)
|
| 020 |
|
|
|a 9780444639493
|
| 020 |
|
|
|z 0444639489
|
| 020 |
|
|
|z 9780444639486
|
| 035 |
|
|
|a (OCoLC)1013722829
|z (OCoLC)1006380904
|z (OCoLC)1006602460
|z (OCoLC)1018225386
|z (OCoLC)1058955665
|
| 050 |
|
4 |
|a RM302.5
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.7042
|2 23
|
| 245 |
0 |
0 |
|a Side effects of drugs annual.
|n Volume 39,
|p A worldwide yearly survey of new data in adverse drug reactions /
|c editor, Sidhartha D. Ray.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands ;
|a Oxford, England ;
|a Cambridge, Massachusetts :
|b Elsevier,
|c 2017.
|
| 264 |
|
4 |
|c �2017
|
| 300 |
|
|
|a 1 online resource (584 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Front Cover -- A Worldwide Yearly Survey of New Data in Adverse Drug Reactions -- Copyright -- Contributors -- Contents -- Preface -- Special Reviews in SEDA 39 -- Table of Essays, Annuals 1�a#x80;#x93;38 -- Abbreviations -- ADRs, ADEs and SEDs: A Bird's Eye View -- Introduction -- Analysis of ADEs, ADRs, Side Effects and Toxicity -- Terminology -- EIDOS -- DoTS -- WHO Classification -- References on Adverse Drug Reactions -- Pharmacogenomics Considerations -- Enzymes and Transporters -- Human Leukocyte Antigens (HLA) -- Genetic Testing Technology
|
| 505 |
8 |
|
|a ConclusionReferences -- Immunological Reactions -- Type I Reactions (IgE-Mediated Anaphylaxis; Immediate Hypersensitivity) -- Type II Reactions (Cytotoxic Reactions) -- Type III Reactions (Immune Complex Reactions) -- Type IV Reactions (Cell-Mediated or Delayed Hypersensitivity Reactions) -- Other Types of Reactions -- References -- Analysis of Toxicological Reactions -- Potentiation Reactions -- Examples: -- Synergistic Effect -- Additive Effect -- Examples: -- Antagonistic Effects -- Examples: -- References -- Grades of Adverse Drug Reactions
|
| 505 |
8 |
|
|a SEDA-38, 1]Organs and Systems -- Cardiovascular -- Reproductive Systems -- Skin -- Drug�a#x80;#x93;Drug Interaction -- Methylxanthines -- Caffeine [SEDA-32, 14; SEDA-33, 11; SEDA-34, 6; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Organs and Systems -- Cardiovascular -- Selective Norepinephrine Reuptake Inhibitors Atomoxetine [SEDA-34, 4; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Organ and Systems -- Drug-Drug Interactions -- Vigilance Promoting Drugs -- Modafinil and Armodafinil [SEDA-34, 6; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Organs and Systems
|
| 505 |
8 |
|
|a PsychiatricDrugs That Suppress Appetite [SEDA-34, 8; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Phentermine [SEDA-34, 8; SEDA-36, 1, SEDA-37, 1; SEDA-38, 1] -- Organs and Systems -- Gastrointestinal -- Parasympathomimetics [SEDA-34, 9, SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Donepezil [SEDA-34, 10; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Organ and Systems -- Psychiatric -- Memantine [SEDA-34, 1] -- Organ and Systems -- Cardiovascular -- Rivastigmine [SEDA-34, 10; SEDA-36, 1; SEDA-37, 1; SEDA-38, 1] -- Organ and Systems -- Skin -- References
|
| 650 |
|
0 |
|a Drugs
|x Side effects.
|
| 650 |
|
2 |
|a Drug-Related Side Effects and Adverse Reactions
|0 (DNLM)D064420
|
| 650 |
|
6 |
|a M�edicaments
|x Effets secondaires.
|0 (CaQQLa)201-0002241
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Side effects
|2 fast
|0 (OCoLC)fst00898912
|
| 700 |
1 |
|
|a Ray, Sidhartha D.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Side effects of drugs annual. Volume 39, A worldwide yearly survey of new data in adverse drug reactions.
|d Amsterdam, Netherlands ; Oxford, England ; Cambridge, Massachusetts : Elsevier, 2017
|z 0444639489
|z 9780444639486
|w (OCoLC)987359055
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/03786080/39
|z Texto completo
|
